Compounds > benzoxazoles
Page last updated: 2024-08-21

benzoxazoles and Cancer of Prostate

benzoxazoles has been researched along with Cancer of Prostate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kostin, VA; Kuzikov, AV; Latysheva, AS; Misharin, AY; Morozevich, GE; Novikov, RA; Shumyantseva, VV; Timofeev, VP; Tkachev, YV; Zolottsev, VA1
Chen, J; Dai, Q; Gao, S; Huang, S; Huang, Z; Jiang, W; Lu, Y; Ren, F; Shi, Y; Wu, X1
Jiang, SJ; Wang, S1
Adedeji, D; Bakare, O; Brandy, Y; Butcher, RJ; Copeland, RL; Denmeade, SR; Kanaan, Y; Mouamba, C; Ononiwu, I; Williams, V; Wright, DA1
Bonham, MJ; Christensen, C; Edlind, MP; Feldman, ME; Hsieh, AC; Ingolia, NT; Janes, MR; Jessen, K; Liu, Y; Martin, M; Ren, P; Rommel, C; Ruggero, D; Sher, A; Shi, EY; Shokat, KM; Stumpf, CR; Wang, S; Weissman, JS1

Other Studies

5 other study(ies) available for benzoxazoles and Cancer of Prostate

ArticleYear
Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.
    Steroids, 2018, Volume: 129

    Topics: Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Electrochemistry; Humans; Male; Molecular Docking Simulation; Norpregnenes; Oxazoles; Prostatic Neoplasms; Protein Conformation; Steroid 17-alpha-Hydroxylase

2018
Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Animals; Benzoxazoles; Cell Death; Cell Line, Tumor; Cell Movement; Collagen Type IV; Disulfides; DNA; Endocytosis; Gene Transfer Techniques; Genetic Therapy; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Particle Size; Peptide Fragments; Plasmids; Polyethylene Glycols; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Quinolinium Compounds; Static Electricity; Tissue Distribution; Transfection; Transferrin

2018
Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:10

    Topics: Animals; Apoptosis; Benzoxazoles; Blotting, Western; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Nude; Multiprotein Complexes; Prostatic Neoplasms; Pyrimidines; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015
Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.
    Investigational new drugs, 2012, Volume: 30, Issue:4

    Topics: Androgens; Benzoxazoles; Cell Death; Cell Line, Tumor; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Male; Naphthoquinones; Oxazoles; Prostatic Neoplasms

2012
The translational landscape of mTOR signalling steers cancer initiation and metastasis.
    Nature, 2012, Feb-22, Volume: 485, Issue:7396

    Topics: Adaptor Proteins, Signal Transducing; Animals; Benzoxazoles; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factors; Gene Expression Regulation, Neoplastic; Genome; Humans; Male; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphoproteins; Prostatic Neoplasms; Protein Biosynthesis; Pyrimidines; Repressor Proteins; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases

2012